Physician Mistrust, Medical System Mistrust, and Perceived Discrimination: Associations with HIV Care Engagement and Viral Load
- PMID: 30879211
- PMCID: PMC6854532
- DOI: 10.1007/s10461-019-02464-1
Physician Mistrust, Medical System Mistrust, and Perceived Discrimination: Associations with HIV Care Engagement and Viral Load
Abstract
Medical mistrust is an important risk factor for many health outcomes. For individuals with HIV and substance use co-morbidities, mistrust may influence engagement with health care, and affect overall health and transmission risk. Medical mistrust can be measured by an individual's mistrust of his/her physician, or mistrust of the medical system. This study examined both types of mistrust among 801 substance-using individuals with uncontrolled HIV infection. The aims were to determine how physician mistrust, medical system mistrust, and discrimination experiences were associated with engagement in HIV primary care. Findings indicated higher levels of physician mistrust, but not medical system mistrust, were associated with a longer time since the last visit to an HIV provider. Longer time since seeing an HIV care provider was associated with higher viral load. This study refines our understanding of the relationship between mistrust and HIV care engagement for a large, diverse sample of substance-using individuals.
Keywords: Discrimination; HIV; Health care engagement; Medical mistrust.
Figures
References
-
- White House Office of National AIDS Policy. National HIV/AIDS strategy for the United States: Updated to 2020 www.aids.gov/federal-resources/national-hiv-aids-strategy/nhasupdate.pdf
-
- Centers for Disease Control and Prevention. Understanding the HIV care continuum. Centers for Disease Control and Prevention; 2016
-
- Benítez-Gutiérrez L, Soriano V, Requena S, Arias A, Barreiro P, de Mendoza C. Treatment and prevention of HIV infection with long-acting antiretrovirals. Expert Rev Clin Pharmacol. 2018;11(5):507–17. - PubMed
-
- Ford N, Ball A, Baggaley R, Vitoria M, Low-Beer D, Penazzato M, et al. The WHO public health approach to HIV treatment and care: looking back and looking ahead. Lancet Infect Dis. 2018;18(3):e76–e86. - PubMed
MeSH terms
Substances
Grants and funding
- UG1 DA020024/DA/NIDA NIH HHS/United States
- P30 AI050409/AI/NIAID NIH HHS/United States
- UG1 DA013034/DA/NIDA NIH HHS/United States
- UG1 DA015815/DA/NIDA NIH HHS/United States
- UG1 DA013720/DA/NIDA NIH HHS/United States
- P30AI050409/Foundation for the National Institutes of Health
- U10 DA020024/DA/NIDA NIH HHS/United States
- UG1 DA013727/DA/NIDA NIH HHS/United States
- U10DA013035/DA/NIDA NIH HHS/United States
- U10 DA015815/DA/NIDA NIH HHS/United States
- U10 DA013720/DA/NIDA NIH HHS/United States
- U10 DA015831/DA/NIDA NIH HHS/United States
- U10 DA013035/DA/NIDA NIH HHS/United States
- T32 DA037801/DA/NIDA NIH HHS/United States
- U10 DA020036/DA/NIDA NIH HHS/United States
- UG1 DA015831/DA/NIDA NIH HHS/United States
- UG1 DA013035/DA/NIDA NIH HHS/United States
- U10 DA013732/DA/NIDA NIH HHS/United States
- U10DA020024/DA/NIDA NIH HHS/United States
- U10 DA013043/DA/NIDA NIH HHS/United States
- T32-DA037801/DA/NIDA NIH HHS/United States
- U10DA013720/DA/NIDA NIH HHS/United States
- U10 DA013045/DA/NIDA NIH HHS/United States
- U10DA013034/DA/NIDA NIH HHS/United States
- U10 DA013034/DA/NIDA NIH HHS/United States
- R01 DA041063/DA/NIDA NIH HHS/United States
- U10DA015815/DA/NIDA NIH HHS/United States
- U10 DA013727/DA/NIDA NIH HHS/United States
- UG1 DA013732/DA/NIDA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
